Saturday, 17 October 2026European Markets

GC RIEBER SHIPPING Stock Bullish By 29% In The Last 21 Sessions

Loading stream...

(VIANEWS) - Shares of GC RIEBER SHIPPING (Oslo Børs All-share Index_GI: RISH.OL) jumped by a staggering 29.5% in 21 sessions from $10 to $12.95 at 13:40 EST on Tuesday, after three sequential sessions in a row of gains. Oslo Børs All-share Index_GI is rising 0.84% to $1,377.27, after consecutive sessions in a row of losses.

About GC RIEBER SHIPPING

GC Rieber Shipping ASA operates as a ship owner and project house with a focus on developing maritime projects in Norway and internationally. It also provides services for scientific expeditions and logistics operations, as well as services to the oil and gas sector. The company was founded in 1879 and is headquartered in Bergen, Norway. GC Rieber Shipping ASA is a subsidiary of GC Rieber AS.

Earnings Per Share

As for profitability, GC RIEBER SHIPPING has a trailing twelve months EPS of $2.57.

PE Ratio

GC RIEBER SHIPPING has a trailing twelve months price to earnings ratio of 5.04. Meaning, the purchaser of the share is investing $5.04 for every dollar of annual earnings.

Volume

Today's last reported volume for GC RIEBER SHIPPING is 18730 which is 115.06% above its average volume of 8709.

More news about GC RIEBER SHIPPING (RISH.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com